- Home
- EIM vs ANGO Comparison
EIM vs ANGO Comparison
Compare EIM & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIM | ANGO |
|---|---|---|
| Founded | 2002 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.7M | 550.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | EIM | ANGO |
|---|---|---|
| Price | $9.68 | $13.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 215.2K | ★ 417.7K |
| Earning Date | 01-01-0001 | 01-06-2026 |
| Dividend Yield | ★ 4.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $8.61 | $8.27 |
| 52 Week High | $10.51 | $13.99 |
Technical Indicators
Market Signals| Indicator | EIM | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 30.55 | 52.98 |
| Support Level | $9.63 | $13.12 |
| Resistance Level | $9.77 | $13.91 |
| Average True Range (ATR) | 0.05 | 0.37 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 13.64 | 24.27 |
Price Performance
Historical ComparisonAbout EIM Eaton Vance Municipal Bond
Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.